Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Okada

Showing results (391-400 of 443) with videos related to

Pageof 45
Sort By:
ESC Heart Failure|March 24, 2021
Prognostic significance of the HFA-PEFF score in patients with heart failure with preserved ejection fractionYohei Sotomi, Katsuomi Iwakura, Shungo Hikoso, et al.
International Immunology|September 2, 2022
SARS-CoV-2 ORF8 is a viral cytokine regulating immune responsesMasako Kohyama, Tatsuya Suzuki, Wataru Nakai, et al.
Viruses|December 23, 2023
Enhancement of SARS-CoV-2 Infection via Crosslinking of Adjacent Spike Proteins by N-Terminal Domain-Targeting AntibodiesTina Lusiany, Tohru Terada, Jun-Ichi Kishikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2006
Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasisShigeru Hashimoto, Mayumi Hirose, Ari Hashimoto, et al.
Annals of the Rheumatic Diseases|July 15, 2020
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52Josef S Smolen, Philip Mease, Hasan Tahir, et al.
Journal of the American Heart Association|July 30, 2025
Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection FractionMasato Okada, Nobuaki Tanaka, Katsuomi Iwakura, et al.
Journal of Cardiology|September 16, 2025
Cardiothoracic ratio as a prognostic marker in heart failure with preserved ejection fractionMasato Okada, Koichi Inoue, Toshinari Onishi, et al.
Nature Medicine|April 30, 2025
Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trialMasaharu Masuda, Akihiro Sunaga, Nobuaki Tanaka, et al.
Scientific Reports|January 19, 2024
The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fractionKatsuomi Iwakura, Toshinari Onishi, Atsunori Okamura, et al.
JACC. Asia|May 21, 2026
Triglyceride-Glucose Index and Clinical Outcome in Patients With Heart Failure With Preserved Ejection FractionKatsuomi Iwakura, Atsunori Okamura, Yoshitaka Iwanaga, et al.
Pageof 45

Showing results (391-400 of 443) with videos related to

Sort By:
Pageof 45
ESC Heart Failure|March 24, 2021
Prognostic significance of the HFA-PEFF score in patients with heart failure with preserved ejection fractionYohei Sotomi, Katsuomi Iwakura, Shungo Hikoso, et al.
International Immunology|September 2, 2022
SARS-CoV-2 ORF8 is a viral cytokine regulating immune responsesMasako Kohyama, Tatsuya Suzuki, Wataru Nakai, et al.
Viruses|December 23, 2023
Enhancement of SARS-CoV-2 Infection via Crosslinking of Adjacent Spike Proteins by N-Terminal Domain-Targeting AntibodiesTina Lusiany, Tohru Terada, Jun-Ichi Kishikawa, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 26, 2006
Targeting AMAP1 and cortactin binding bearing an atypical src homology 3/proline interface for prevention of breast cancer invasion and metastasisShigeru Hashimoto, Mayumi Hirose, Ari Hashimoto, et al.
Annals of the Rheumatic Diseases|July 15, 2020
Multicentre, randomised, open-label, parallel-group study evaluating the efficacy and safety of ixekizumab versus adalimumab in patients with psoriatic arthritis naïve to biological disease-modifying antirheumatic drug: final results by week 52Josef S Smolen, Philip Mease, Hasan Tahir, et al.
Journal of the American Heart Association|July 30, 2025
Left Atrial Volumetric/Mechanical Coupling Index in Heart Failure With Preserved Ejection FractionMasato Okada, Nobuaki Tanaka, Katsuomi Iwakura, et al.
Journal of Cardiology|September 16, 2025
Cardiothoracic ratio as a prognostic marker in heart failure with preserved ejection fractionMasato Okada, Koichi Inoue, Toshinari Onishi, et al.
Nature Medicine|April 30, 2025
Low-voltage-area ablation for persistent atrial fibrillation: a randomized controlled trialMasaharu Masuda, Akihiro Sunaga, Nobuaki Tanaka, et al.
Scientific Reports|January 19, 2024
The WATCH-DM risk score estimates clinical outcomes in type 2 diabetic patients with heart failure with preserved ejection fractionKatsuomi Iwakura, Toshinari Onishi, Atsunori Okamura, et al.
JACC. Asia|May 21, 2026
Triglyceride-Glucose Index and Clinical Outcome in Patients With Heart Failure With Preserved Ejection FractionKatsuomi Iwakura, Atsunori Okamura, Yoshitaka Iwanaga, et al.
Pageof 45